⌘K
Loading ticker…
As of 2026-08-24, agilon health, inc. (AGL) has a 3-month relative strength percentile of 64 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 99. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.5%, relative volume 0.56×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
AGL is held by 17 ETFs as of May 2026. Top owner: FNDA at 0.18% weight, $16M notional. Top 3 carry $28M.
Held by 28 ETFs · $49M across latest filings · largest weight 1.95% (ISMD).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| FNDA | 0.18% | $16M | new |
| ISMD | 1.95% | $6M | new |
| VTWO | 0.03% | $6M | new |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $6M | new |
| VHTVanguard Health Care ETF | 0.02% | $3M | new |
| VTWG | 0.06% | $1M | new |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | new |
| AVSC | 0.01% | $313K | new |
| FNDB | 0.02% | $207K | new |
| AVUSAvantis U.S. Equity ETF | 0.00% | $142K | new |
Showing 10 of 17 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AGL Jan avg: 19.60% median: 27.83% win: 75% σ: 53.76% n: 4 2022-04-12 → 2026-07-31 | AGL Feb avg: -8.56% median: -4.56% win: 25% σ: 14.44% n: 4 2022-04-12 → 2026-07-31 | AGL Mar avg: 0.99% median: 5.74% win: 50% σ: 35.54% n: 4 2022-04-12 → 2026-07-31 | AGL Apr avg: 43.81% median: -1.62% win: 40% σ: 117.60% n: 5 2022-04-12 → 2026-07-31 | AGL May avg: 37.24% median: 7.49% win: 60% σ: 110.60% n: 5 2022-04-12 → 2026-07-31 | AGL Jun avg: 5.01% median: 3.81% win: 80% σ: 11.51% n: 5 2022-04-12 → 2026-07-31 | AGL Jul avg: -1.25% median: 5.35% win: 60% σ: 16.18% n: 5 2022-04-12 → 2026-07-31 | AGL Aug avg: -23.43% median: -22.74% win: 0% σ: 14.41% n: 4 2022-04-12 → 2026-07-31 (current) | AGL Sep avg: -2.57% median: -1.73% win: 50% σ: 13.29% n: 4 2022-04-12 → 2026-07-31 | AGL Oct avg: -17.92% median: -18.96% win: 25% σ: 15.24% n: 4 2022-04-12 → 2026-07-31 | AGL Nov avg: -22.21% median: -18.15% win: 0% σ: 12.91% n: 4 2022-04-12 → 2026-07-31 | AGL Dec avg: 1.69% median: -1.16% win: 50% σ: 12.91% n: 4 2022-04-12 → 2026-07-31 |